Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Cts Sibinga"'
Publikováno v:
British Journal of Haematology. 109:776-784
Increasing the number of megakaryocyte progenitors in stem cell transplants by ex vivo expansion culture may be an approach to accelerate platelet recovery in patients undergoing high-dose chemotherapy. We evaluated the effect of three different cyto
Autor:
J. T. M. de Wolf, Cts Sibinga, Sjoerd Hovenga, Jeroen E. J. Guikema, Nicolaas A. Bos, H. Klip, Edo Vellenga, J. W. Smit
Publikováno v:
Bone marrow transplantation, 25(7), 723-728. Nature Publishing Group
Bone marrow transplantation, 88(10), 723-728. Nature Publishing Group
Bone marrow transplantation, 88(10), 723-728. Nature Publishing Group
Thirty-seven patients with multiple myeloma (stage II and III, 65% increased beta 2-microglobulin level) were prospectively treated with a median of 3.7 VAD courses (range 2-8) followed by cyclophosphamide (6 g/m(2)) in conjunction with G-CSF (5 mu g
Publikováno v:
Bone marrow transplantation, 24(9), 1015-1018. Nature Publishing Group
Reinfusion of autologous hematopoietic peripheral blood stem cells (PBSC) or bone marrow is often accompanied by flushing, dyspnea, abdominal cramping, nausea and diarrhea. These symptoms and the observation that they can be prevented by ondansetron,
Autor:
P. M. Pelsma, Cts Sibinga, J van der Meer, PJ de Kam, C. M. A. Henkens, W van der Schaaf, V. J. J. Bom
Publikováno v:
Thrombosis and Haemostasis. 74:1271-1275
SummaryWe measured total and free protein S (PS), protein C (PC) and factor X (FX) in 393 healthy blood donors to assess differences in relation to sex, hormonal state and age. All measured proteins were lower in women as compared to men, as were lev
Publikováno v:
Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65fc416e4b2fc3c2b5e60b7b93fcacf0
https://doi.org/10.1007/978-1-4615-1735-1
https://doi.org/10.1007/978-1-4615-1735-1
Publikováno v:
Transfusion Medicine: Quo Vadis? What Has Been Achieved, What Is to Be Expected ISBN: 9781461357001
Up to today, safety for transfusion of blood and blood products has been determined by supply of available technology. The goal of public health authorities in this field has been to achieve maximum transfusion safety. For example, newer, better and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79a9562bc9ab96095392345edac102a7
https://doi.org/10.1007/978-1-4615-1735-1_5
https://doi.org/10.1007/978-1-4615-1735-1_5
Publikováno v:
Human genetics. 99(1)
An average cystic fibrosis (CF) carrier frequency of 1 in 25 in Europe is cited in numerous reports, although a great variability in estimated prevalences has been found in different European populations. The estimates of these frequencies were based
Autor:
Mhr vanVeldhuizen, Lp Tenkate, Jm Collee, Chcm Buys, L Achterhof, H Devries, Hans Scheffer, Cts Sibinga
Publikováno v:
Human genetics. 97(3)
Mouthwashes can be used as a DNA resource for mutation detection and, because collection and DNA isolation is simple and cheap, they could in particular, be used for large numbers of samples. To determine the failure rate (the proportion of mouth sam
Publikováno v:
Blood. 86:3263-3264
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 19:120-124
Bleeding prophylaxis with cryopreserved autologous thrombocytes was evaluated in 43 patients treated with high-dose chemotherapy and autologous bone marrow transplantation. Platelet transfusions were given prophylactically. Nineteen patients received